S&P 500   5,131.69 (+0.70%)
DOW   39,050.68 (+0.14%)
QQQ   445.60 (+1.50%)
AAPL   179.06 (-0.93%)
MSFT   414.98 (+0.32%)
META   502.36 (+2.50%)
GOOGL   138.22 (-0.17%)
AMZN   178.52 (+1.00%)
TSLA   204.24 (+1.17%)
NVDA   819.35 (+3.57%)
NIO   5.84 (+1.57%)
AMD   201.40 (+4.61%)
BABA   74.80 (+1.04%)
T   16.99 (+0.35%)
F   12.44 (+0.00%)
MU   95.90 (+5.84%)
CGC   3.24 (-1.52%)
GE   159.01 (+1.35%)
DIS   111.99 (+0.37%)
AMC   4.40 (+1.85%)
PFE   26.57 (+0.04%)
PYPL   60.65 (+0.51%)
XOM   105.79 (+1.22%)
S&P 500   5,131.69 (+0.70%)
DOW   39,050.68 (+0.14%)
QQQ   445.60 (+1.50%)
AAPL   179.06 (-0.93%)
MSFT   414.98 (+0.32%)
META   502.36 (+2.50%)
GOOGL   138.22 (-0.17%)
AMZN   178.52 (+1.00%)
TSLA   204.24 (+1.17%)
NVDA   819.35 (+3.57%)
NIO   5.84 (+1.57%)
AMD   201.40 (+4.61%)
BABA   74.80 (+1.04%)
T   16.99 (+0.35%)
F   12.44 (+0.00%)
MU   95.90 (+5.84%)
CGC   3.24 (-1.52%)
GE   159.01 (+1.35%)
DIS   111.99 (+0.37%)
AMC   4.40 (+1.85%)
PFE   26.57 (+0.04%)
PYPL   60.65 (+0.51%)
XOM   105.79 (+1.22%)
S&P 500   5,131.69 (+0.70%)
DOW   39,050.68 (+0.14%)
QQQ   445.60 (+1.50%)
AAPL   179.06 (-0.93%)
MSFT   414.98 (+0.32%)
META   502.36 (+2.50%)
GOOGL   138.22 (-0.17%)
AMZN   178.52 (+1.00%)
TSLA   204.24 (+1.17%)
NVDA   819.35 (+3.57%)
NIO   5.84 (+1.57%)
AMD   201.40 (+4.61%)
BABA   74.80 (+1.04%)
T   16.99 (+0.35%)
F   12.44 (+0.00%)
MU   95.90 (+5.84%)
CGC   3.24 (-1.52%)
GE   159.01 (+1.35%)
DIS   111.99 (+0.37%)
AMC   4.40 (+1.85%)
PFE   26.57 (+0.04%)
PYPL   60.65 (+0.51%)
XOM   105.79 (+1.22%)
S&P 500   5,131.69 (+0.70%)
DOW   39,050.68 (+0.14%)
QQQ   445.60 (+1.50%)
AAPL   179.06 (-0.93%)
MSFT   414.98 (+0.32%)
META   502.36 (+2.50%)
GOOGL   138.22 (-0.17%)
AMZN   178.52 (+1.00%)
TSLA   204.24 (+1.17%)
NVDA   819.35 (+3.57%)
NIO   5.84 (+1.57%)
AMD   201.40 (+4.61%)
BABA   74.80 (+1.04%)
T   16.99 (+0.35%)
F   12.44 (+0.00%)
MU   95.90 (+5.84%)
CGC   3.24 (-1.52%)
GE   159.01 (+1.35%)
DIS   111.99 (+0.37%)
AMC   4.40 (+1.85%)
PFE   26.57 (+0.04%)
PYPL   60.65 (+0.51%)
XOM   105.79 (+1.22%)

Acasti Pharma (ACST) Short Interest Ratio & Short Volume

$3.40
+0.06 (+1.80%)
(As of 01:05 PM ET)

Acasti Pharma Short Interest Data

Current Short Volume
11,300 shares
Previous Short Volume
23,600 shares
Change Vs. Previous Month
-52.12%
Dollar Volume Sold Short
$34,578.00
Short Interest Ratio / Days to Cover
0.4
Last Record Date
February 15, 2024
Outstanding Shares
9,400,000 shares
Float Size
6,250,000 shares
Short Percent of Float
0.18%
Today's Trading Volume
5,858 shares
Average Trading Volume
25,859 shares
Today's Volume Vs. Average
23%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Acasti Pharma ?

Sign up to receive the latest short interest report for Acasti Pharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ACST Short Interest Over Time

ACST Days to Cover Over Time

ACST Percentage of Float Shorted Over Time


Acasti Pharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/15/202411,300 shares $34,578.00 -52.1%0.2%0.4 $3.06
1/31/202423,600 shares $59,472.00 +20.4%0.4%1.1 $2.52
1/15/202419,600 shares $52,528.00 -73.5%0.3%0.9 $2.68
12/31/202373,900 shares $213,571.00 +23.8%1.1%3.5 $2.89
12/15/202359,700 shares $128,355.00 -22.3%0.9%1.1 $2.15
11/30/202376,800 shares $166,656.00 -16.4%1.3%1.5 $2.17
11/15/202391,900 shares $200,342.00 -10.0%1.5%1.9 $2.18
10/31/2023102,100 shares $240,956.00 -8.8%2.1%2 $2.36
10/15/2023112,000 shares $291,200.00 -48.9%2.4%2.2 $2.60
9/30/2023219,200 shares $610,143.20 +1,401.4%4.6%3.9 $2.78
9/15/202314,600 shares $29,054.00 -22.8%0.3%0.3 $1.99
8/31/202318,900 shares $39,690.00 -19.6%0.4%0.7 $2.10
8/15/202323,500 shares $52,875.00 +27.7%0.4%0.9 $2.25
7/31/202318,400 shares $47,472.00 +10.2%0.3%0.7 $2.58
7/15/202316,700 shares $41,750.00 -46.1%0.2%0.7 $2.50
6/30/202331,000 shares $97,668.60 -89.7%N/A1.5 $3.15
6/15/2023301,400 shares $173,274.86 -28.0%0.8%4.8 $0.57
5/31/2023418,300 shares $225,882.00 -19.5%1.1%7 $0.54
5/15/2023519,500 shares $252,165.30 +1.5%1.3%8.6 $0.49
4/30/2023511,900 shares $232,402.60 -2.4%1.3%8.4 $0.45
4/15/2023524,300 shares $246,316.14 +3.6%1.3%6.9 $0.47
3/31/2023506,300 shares $232,847.37 +5.4%1.3%5.4 $0.46
3/15/2023480,600 shares $211,464.00 +58.1%1.4%2.4 $0.44
2/28/2023303,900 shares $155,596.80 +41.1%0.9%1.4 $0.51
2/15/2023215,400 shares $137,877.54 +31.9%0.6%1 $0.64
1/31/2023163,300 shares $115,959.33 -18.6%0.5%0.7 $0.71
1/15/2023200,700 shares $142,497.00 -50.0%0.6%0.9 $0.71
12/30/2022401,100 shares $200,951.10 +537.7%1.2%2 $0.50
12/15/202262,900 shares $22,165.96 +103.6%0.2%0.5 $0.35
11/30/202230,900 shares $12,940.92 -42.2%0.1%0.4 $0.42
11/15/202253,500 shares $26,599.29 -41.7%0.2%0.8 $0.50
10/31/202291,700 shares $51,902.20 -13.9%0.3%1.5 $0.57
10/15/2022106,500 shares $58,575.00 -22.2%0.3%1.6 $0.55
9/30/2022136,900 shares $79,881.15 -4.3%0.4%2 $0.58
9/15/2022143,000 shares $112,398.00 -7.1%0.4%2 $0.79
8/31/2022154,000 shares $125,294.40 -32.2%0.4%2 $0.81
8/15/2022227,200 shares $215,840.00 -20.4%0.7%2.6 $0.95
7/31/2022285,400 shares $236,339.74 -13.7%0.9%2.7 $0.83
7/15/2022330,500 shares $285,882.50 -58.1%1.0%3.3 $0.87
6/30/2022788,700 shares $681,436.80 -9.5%2.5%7.4 $0.86













ACST Short Interest - Frequently Asked Questions

What is Acasti Pharma's current short interest?

Short interest is the volume of Acasti Pharma shares that have been sold short but have not yet been covered or closed out. As of February 15th, investors have sold 11,300 shares of ACST short. 0.18% of Acasti Pharma's shares are currently sold short. Learn More on Acasti Pharma's current short interest.

What is a good short interest percentage for Acasti Pharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.18% of Acasti Pharma's floating shares are currently sold short.

Is Acasti Pharma's short interest increasing or decreasing?

Acasti Pharma saw a decline in short interest in February. As of February 15th, there was short interest totaling 11,300 shares, a decline of 52.1% from the previous total of 23,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Acasti Pharma's float size?

Acasti Pharma currently has issued a total of 9,400,000 shares. Some of Acasti Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acasti Pharma currently has a public float of 6,250,000 shares.

How does Acasti Pharma's short interest compare to its competitors?

0.18% of Acasti Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Acasti Pharma: Bullfrog AI Holdings, Inc. (11.05%), Cumberland Pharmaceuticals Inc. (0.33%), Unity Biotechnology, Inc. (2.08%), Regulus Therapeutics Inc. (0.56%), SELLAS Life Sciences Group, Inc. (12.13%), Marker Therapeutics, Inc. (2.78%), DURECT Co. (3.56%), VYNE Therapeutics Inc. (0.30%), Viracta Therapeutics, Inc. (2.53%), eFFECTOR Therapeutics, Inc. (4.91%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Super Micro Computer, Inc. ($5.32 billion), T-Mobile US, Inc. ($4.38 billion), General Motors ($3.76 billion), Occidental Petroleum Co. ($3.08 billion), Charter Communications, Inc. ($2.65 billion), Coinbase Global, Inc. ($2.62 billion), Tractor Supply ($2.52 billion), Moderna, Inc. ($2.19 billion), Rivian Automotive, Inc. ($1.84 billion), and Royal Caribbean Cruises Ltd. ($1.78 billion). View all of the most shorted stocks.

What does it mean to sell short Acasti Pharma stock?

Short selling ACST is an investing strategy that aims to generate trading profit from Acasti Pharma as its price is falling. ACST shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Acasti Pharma?

A short squeeze for Acasti Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ACST, which in turn drives the price of the stock up even further.

How often is Acasti Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACST, twice per month. The most recent reporting period available is February, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ACST) was last updated on 3/1/2024 by MarketBeat.com Staff